Frazer IH - Search Results

1

Evolution of Cancer Vaccines-Challenges, Achievements, and Future Directions.

Tay BQ, Wright Q, Ladwa R, Perry C, Leggatt G, Simpson F, Wells JW, Panizza BJ, Frazer IH, Cruz JLG. Tay BQ, et al. Among authors: frazer ih. Vaccines (Basel). 2021 May 20;9(5):535. doi: 10.3390/vaccines9050535. Vaccines (Basel). 2021. PMID: 34065557 Free PMC article. Review.

2

Split tolerance to a viral antigen expressed in thymic epithelium and keratinocytes.

Frazer IH, Fernando GJ, Fowler N, Leggatt GR, Lambert PF, Liem A, Malcolm K, Tindle RW. Frazer IH, et al. Eur J Immunol. 1998 Sep;28(9):2791-800. doi: 10.1002/(SICI)1521-4141(199809)28:09<2791::AID-IMMU2791>3.0.CO;2-B. Eur J Immunol. 1998. PMID: 9754566 Free article.

3

Potential strategies utilised by papillomavirus to evade host immunity.

Frazer IH, Thomas R, Zhou J, Leggatt GR, Dunn L, McMillan N, Tindle RW, Filgueira L, Manders P, Barnard P, Sharkey M. Frazer IH, et al. Immunol Rev. 1999 Apr;168:131-42. doi: 10.1111/j.1600-065x.1999.tb01288.x. Immunol Rev. 1999. PMID: 10399070 Review.

4

Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes.

Liu WJ, Liu XS, Zhao KN, Leggatt GR, Frazer IH. Liu WJ, et al. Among authors: frazer ih. Virology. 2000 Aug 1;273(2):374-82. doi: 10.1006/viro.2000.0435. Virology. 2000. PMID: 10915608 Free article.

5

Nonspecific down-regulation of CD8+ T-cell responses in mice expressing human papillomavirus type 16 E7 oncoprotein from the keratin-14 promoter.

Tindle RW, Herd K, Doan T, Bryson G, Leggatt GR, Lambert P, Frazer IH, Street M. Tindle RW, et al. Among authors: frazer ih. J Virol. 2001 Jul;75(13):5985-97. doi: 10.1128/JVI.75.13.5985-5997.2001. J Virol. 2001. PMID: 11390600 Free PMC article.

6

Tolerance or immunity to a tumor antigen expressed in somatic cells can be determined by systemic proinflammatory signals at the time of first antigen exposure.

Frazer IH, De Kluyver R, Leggatt GR, Guo HY, Dunn L, White O, Harris C, Liem A, Lambert P. Frazer IH, et al. J Immunol. 2001 Dec 1;167(11):6180-7. doi: 10.4049/jimmunol.167.11.6180. J Immunol. 2001. PMID: 11714778

7

Polynucleotide viral vaccines: codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy.

Liu WJ, Zhao KN, Gao FG, Leggatt GR, Fernando GJ, Frazer IH. Liu WJ, et al. Among authors: frazer ih. Vaccine. 2001 Dec 12;20(5-6):862-9. doi: 10.1016/s0264-410x(01)00406-6. Vaccine. 2001. PMID: 11738751

8

Route of administration of chimeric BPV1 VLP determines the character of the induced immune responses.

Liu XS, Liu WJ, Zhao KN, Liu YH, Leggatt G, Frazer IH. Liu XS, et al. Among authors: frazer ih. Immunol Cell Biol. 2002 Feb;80(1):21-9. doi: 10.1046/j.1440-1711.2002.01051.x. Immunol Cell Biol. 2002. PMID: 11869359

9

The number of long-lasting functional memory CD8+ T cells generated depends on the nature of the initial nonspecific stimulation.

Fernando GJ, Khammanivong V, Leggatt GR, Liu WJ, Frazer IH. Fernando GJ, et al. Among authors: frazer ih. Eur J Immunol. 2002 Jun;32(6):1541-9. doi: 10.1002/1521-4141(200206)32:6<1541::AID-IMMU1541>3.0.CO;2-S. Eur J Immunol. 2002. PMID: 12115636 Free article.

10

Interferon-gamma enhances cytotoxic T lymphocyte recognition of endogenous peptide in keratinocytes without lowering the requirement for surface peptide.

Leggatt GR, Dunn LA, De Kluyver RL, Stewart T, Frazer IH. Leggatt GR, et al. Among authors: frazer ih. Immunol Cell Biol. 2002 Oct;80(5):415-24. doi: 10.1046/j.1440-1711.2002.01105.x. Immunol Cell Biol. 2002. PMID: 12225377

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

335 results

Search Page